Jagpal Sukhi
Insider CIK 1554591 · DNAI Chief Financial Officer · STRO Director · QLTI Interim CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2026-06-05 | 2026-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2025-12-23 | 2025-12-29 | 1,500 | — | $0 | 1,500 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2025-06-06 | 2025-06-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2024-08-08 | 2024-08-12 | 35,000 | — | $0 | 35,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2024-08-08 | 2024-08-12 | 28,959 | — | $0 | 28,959 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 49,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 94,113 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 5,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 4,509 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 1,750 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 1,218 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 3,859 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 5,887 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 30,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 50,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 4,200 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2022-06-17 | 2022-06-17 | 12,250 | — | $0 | 12,250 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2022-03-14 | 2022-03-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2022-01-28 | 2022-01-28 | 12,250 | — | $0 | 12,250 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2021-03-15 | 2021-03-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2020-08-12 | 2020-08-12 | 5,887 | — | $0 | 5,887 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2020-02-25 | 2020-02-27 | 94,113 | — | $0 | 94,113 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2019-03-04 | 2019-03-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2018-03-06 | 2018-03-07 | 180,360 | — | $0 | 180,360 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2017-03-06 | 2017-03-08 | 70,000 | — | $0 | 70,000 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | A Award deriv | 2016-09-30 | 2016-10-04 | 168,000 | — | $0 | 168,000 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | A Award deriv | 2016-03-08 | 2016-03-10 | 48,750 | — | $0 | 48,750 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2013-07-15 | 2013-07-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2013-05-14 | 2013-05-15 | 10,000 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | S Sale | 2013-05-14 | 2013-05-15 | 9,900 | $7.95 | $78.7K | 1,300 | SEC↗ |
| QLTI QLT INC/BC | S Sale | 2013-05-14 | 2013-05-15 | 100 | $7.96 | $796 | 1,200 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2013-05-14 | 2013-05-15 | 10,000 | $7.12 | $71.2K | 11,200 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2012-08-03 | 2012-08-07 | 20,000 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2012-08-03 | 2012-08-07 | 15,000 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2012-08-03 | 2012-08-07 | 20,000 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2012-08-03 | 2012-08-07 | 12,000 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2012-08-03 | 2012-08-07 | 15,000 | $2.44 | $36.6K | 36,200 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2012-08-03 | 2012-08-07 | 12,000 | $6.28 | $75.4K | 48,200 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2012-08-03 | 2012-08-07 | 20,000 | $7.21 | $144.2K | 68,200 | SEC↗ |
| QLTI QLT INC/BC | S Sale | 2012-08-03 | 2012-08-07 | 67,000 | $8.19 | $548.7K | 1,200 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2012-08-03 | 2012-08-07 | 20,000 | $3.74 | $74.8K | 21,200 | SEC↗ |